Kalvista Pharmaceuticals Inc (KALV)

Kalvista Pharmaceuticals Inc Azioni (KALV) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-01-31	2023-10-31	2023-07-31	2023-04-30	2023-01-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	11.45% 33.15	29.75	29.09	31.73	26.95
Operating Income/Loss	11.45% -33.15	-29.75	-29.09	-31.73	-26.95
Nonoperating Income/Loss	96.71% 4.123	2.096	3.776	5.423	5.642
Income/Loss From Continuing Operations Before Tax	4.98% -29.03	-27.65	-25.32	-26.30	-21.30
Income/Loss From Continuing Operations After Tax	4.98% -29.03	-27.65	-25.32	-26.30	-21.30
Net Income/Loss	4.98% -29.03	-27.65	-25.32	-26.30	-21.30
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.46% 34.72	34.57	34.41	2.0805	28.28
Diluted Average Shares	0.46% 34.72	34.57	34.41	2.0805	28.28
Basic Earnings Per Share	5.00% -0.84	-0.80	-0.74	-0.75	-0.75
Diluted Earnings Per Share	5.00% -0.84	-0.80	-0.74	-0.75	-0.75
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-